Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations
NCT00692055
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Arthritis
Interventions
DRUG:
PN400
DRUG:
Naproxen
Sponsor
POZEN